J-tube

DEVICE5 trials

Sponsors

AbbVie (prior sponsor, Abbott), AbbVie

Conditions

Advanced Parkinson's DiseaseDyskinesiasParkinson's DiseaseSevere Motor Fluctuations

Phase 3

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

CompletedNCT00335153

AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease

Start: 2008-01-31End: 2012-06-30Updated: 2015-01-16

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

CompletedNCT00357994

AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease

Start: 2009-01-31End: 2011-10-31Updated: 2015-01-16

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

CompletedNCT00360568

AbbVie (prior sponsor, Abbott)Dyskinesias, Parkinson's Disease, Severe Motor Fluctuations

Start: 2009-06-30End: 2012-10-31Updated: 2015-01-16

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

CompletedNCT00660387

AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease

Start: 2009-12-31End: 2011-10-31Updated: 2015-01-16

A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

CompletedNCT01960842

AbbVieAdvanced Parkinson's Disease

Start: 2013-10-31End: 2015-03-31Updated: 2018-05-30

Related Papers

The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson’s disease

Journal of Medical Economics2019-11-159 citations

Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease.

2016-07-146 citations

Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel from an Open-Label Study in Japanese, Taiwanese, and Korean Patients with Advanced Parkinson’s Disease (P5.362)

Neurology2016-04-051 citations

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

2013-12-20470 citations